DuPont de Nemours, Inc. (DD) News
Follow DuPont de Nemours, Inc. (DD) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 51 public stories across 16 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
DuPont Reports Fiscal Q3 Profit, Up 165.39%
DuPont reported fiscal 2026 third-quarter profit attributable to shareholders up 165.39% year over year.
EQUITY | Nov 04, 2026, 05:46 AM UTC
M
DuPont Raises Guidance After Strong Q3 Results; Shares Jump
Third-quarter net sales rose 4% to $1.9 billion, or 5% on an organic basis. Operating EBITDA increased 8% to $469 million, and adjusted EPS rose 62% to $2.09, above estimates of $1.87.
EQUITY | Nov 03, 2026, 04:17 PM UTC
M
DuPont Delivers Beat-and-Raise Quarter as Healthcare and Aerospace Offset Cyclical Weakness
DuPont reported a beat-and-raise quarter, with strength in Healthcare and Aerospace offsetting soft cyclical markets.
EARNINGS | Nov 03, 2026, 03:29 PM UTC
M
DuPont Raises Annual Profit Forecasts, Sees Upbeat Q4
EQUITY | Nov 03, 2026, 03:08 PM UTC
M
DuPont Raises Full-Year Earnings Outlook; Shares Gain More Than 7%
DuPont expects full-year results to reach or exceed the top end of its guidance range, citing strength in healthcare and aerospace. The company also expanded its share repurchase program.
EQUITY | Nov 03, 2026, 03:08 PM UTC
M
DuPont Sees Full-Year Free Cash Flow Conversion About 100%
DuPont said it sees full-year free cash flow conversion of about 100%, above its 90% target, on a conference call.
EARNINGS | Nov 03, 2026, 01:22 PM UTC
M
DuPont Raises Profit Forecast on Strong Demand
DuPont raised its profit forecast, citing strong demand.
EARNINGS | Nov 03, 2026, 12:42 PM UTC
M
DuPont Reports Q3 Earnings and Revenue Rise, Issues Q4 Guidance
DuPont also updated its 2026 outlook. The supplied report does not provide figures or outlook details.
EQUITY | Nov 03, 2026, 11:51 AM UTC
M
DuPont Raises Full-Year Profit Outlook on Strong Healthcare and Aerospace Demand
DuPont’s CFO said full-year results will reach or exceed the high end of guidance. Healthcare and water technologies third-quarter net sales rose 4% year over year.
EQUITY | Nov 03, 2026, 11:34 AM UTC
M
DuPont Reports Third-Quarter 2026 Results, Raises Full-Year Guidance
DuPont said it exceeded its third-quarter 2026 guidance and raised its full-year 2026 guidance. The quarter ended September 30, 2026.
EQUITY | Nov 03, 2026, 11:32 AM UTC
L
DuPont Reports Third-Quarter Adjusted EPS of $2.09
EARNINGS | Nov 03, 2026, 11:14 AM UTC
L
DuPont de Nemours Reports Third-Quarter Continuing Operations EPS of $1.24
EARNINGS | Nov 03, 2026, 11:13 AM UTC
M
DuPont Continuing-Operations EPS Jumps 77% in Q3 2026
EARNINGS | Nov 03, 2026, 11:13 AM UTC
M
DuPont Q3 Sales Beat Estimates; 2026 Profit Outlook Raised
EQUITY | Nov 03, 2026, 11:12 AM UTC
L
DuPont Sees FY26 Sales of $7.19 Billion
EARNINGS | Nov 03, 2026, 11:11 AM UTC
M
DuPont Sees FY Adjusted EPS of $7.47 to
DuPont's FY adjusted EPS outlook is $7.47, versus the IBES estimate of $7.25.
EARNINGS | Nov 03, 2026, 11:10 AM UTC
M
DuPont Expects Q4 Revenue of $1.82B
EQUITY | Nov 03, 2026, 11:08 AM UTC
M
DuPont Sees Fourth-Quarter Sales of $1.825B
EARNINGS | Nov 03, 2026, 11:04 AM UTC
M
DuPont Q3 Sales Reach $1.868 Billion
DuPont reported Q3 sales of $1.868 billion, versus the IBES estimate of $1.843 billion.
EARNINGS | Nov 03, 2026, 11:03 AM UTC
M
DuPont Q3 Operating EBITDA Reaches $469 Million
DuPont reported Q3 operating EBITDA of USD 469 million versus the IBES estimate of USD 449.4 million.
EARNINGS | Nov 03, 2026, 11:02 AM UTC
M
DuPont Sees FY26 Operating EBITDA of About $1.785B
EARNINGS | Nov 03, 2026, 11:02 AM UTC
M
DuPont expects FY organic growth of about 4.5%
EARNINGS | Nov 03, 2026, 11:01 AM UTC
M
DuPont Sees 4Q Operating EBITDA of About $455M
EARNINGS | Nov 03, 2026, 11:01 AM UTC
M
DuPont 3Q Healthcare and Water Technologies Sales Rose 4% to $865M
EARNINGS | Nov 03, 2026, 11:01 AM UTC
M
DuPont’s Third-Quarter Diversified Industrials Sales Rise 4% to $1B
EARNINGS | Nov 03, 2026, 11:01 AM UTC
M
DuPont de Nemours Reports Third-Quarter Sales of $1.9B
EARNINGS | Nov 03, 2026, 11:01 AM UTC
L
DuPont Reports Third-Quarter Net Income of $123M
EARNINGS | Nov 03, 2026, 11:00 AM UTC
M
DuPont de Nemours 3Q Organic Sales Growth Rises 5%
EARNINGS | Nov 03, 2026, 11:00 AM UTC
M
DuPont Q3'26 Earnings Preview: EPS Estimate at 1.87 USD
DuPont is scheduled to report Q3'26 results before the market opens on November 03. Revenue is estimated at 1.84 billion USD, with EPS expected at 1.87 USD.
EQUITY | Nov 02, 2026, 12:01 PM UTC
M
DuPont Q3'26 Earnings Preview: Revenue Estimate 1.84B USD
DuPont is scheduled to report Q3'26 results on November 03 before the market opens. Revenue is estimated at 1.84 billion USD and EPS at 1.87 USD.
EQUITY | Oct 27, 2026, 11:01 AM UTC
M
DuPont Schedules Q3 2026 Earnings Conference Call
DuPont has scheduled its conference call to discuss third quarter 2026 earnings.
EQUITY | Oct 06, 2026, 11:00 AM UTC
L
DD - DuPont Launches Tyvek® with Renewable Attribution for Consumer & Industrial Applications
DD - DuPont Launches Tyvek® with Renewable Attribution for Consumer & Industrial Applications
NEWS | Sep 15, 2026, 01:02 PM UTC
M
DuPont says it likely faces $125M Q2 2026 loss
DuPont told the SEC it likely will record an about $125 million loss in Q2 2026 while agreeing to pay roughly $126 million present value toward a $455 million PFAS settlement with North Carolina and local entities, large
EQUITY | Sep 14, 2026, 11:23 AM UTC
M
Chemours, DuPont and Corteva to pay $455 million in North Carolina PFAS settlement
Chemours, DuPont de Nemours and Corteva settled with North Carolina and 11 communities excluded from a previous settlement over drinking-water PFAS toxins. The $455 million settlement resolves litigation brought by state
EQUITY | Sep 10, 2026, 12:35 PM UTC
H
Chemours, DuPont and Corteva to pay $455M in North Carolina PFAS settlement
Chemours, DuPont de Nemours and Corteva settled with North Carolina and 11 communities excluded from a previous settlement over drinking-water toxins. The parties will pay $455 million to resolve the litigation brought b
EQUITY | Sep 10, 2026, 12:20 PM UTC
M
DuPont, Chemours and Corteva agree $455M PFAS settlement in North Carolina
DuPont, Chemours and Corteva agreed to pay $455 million to settle PFAS contamination claims in North Carolina. The settlement covers discharges tied to the Fayetteville Works manufacturing site and resolves lawsuits by t
EQUITY | Sep 10, 2026, 11:51 AM UTC
M
DuPont de Nemours files to record $125 million probable loss in Q2 2026
DuPont de Nemours, Inc. says in an SEC filing it recorded a probable loss of about $125 million in Q2 2026.
REGULATION | Sep 10, 2026, 11:13 AM UTC
L
DuPont, Chemours and Corteva reach PFAS claims settlement in North Carolina
EQUITY | Sep 10, 2026, 11:01 AM UTC
L
DuPont, Chemours and Corteva agree to resolve PFAS claims in North Carolina
EQUITY | Sep 10, 2026, 11:00 AM UTC
M
Near 50dma resistance TIGO FICO LEN AFRM ESS DOC CXT FIS EXEL AN CNC CZR COST USB STZ BPOP BRKB CTVA ORCL DD TSLA PB MTB KR CL EWBC MCD AMG
Near 50dma resistance TIGO FICO LEN AFRM ESS DOC CXT FIS EXEL AN CNC CZR COST USB STZ BPOP BRKB CTVA ORCL DD TSLA PB MTB KR CL EWBC MCD AMG RF MLI PFG CASY OTIS FCN TPL CAH SFM SBAC NVR
EQUITY | Aug 21, 2026, 06:36 PM UTC
L
DuPont direct lithium extraction team named 2026 Sustainability Squad
DuPont’s direct lithium extraction team is named the 2026 Sustainability Squad by Business Intelligence Group, with no catalyst or financial impact stated in the alert.
EQUITY | Aug 13, 2026, 01:01 PM UTC
L
DD - Australia's Largest Inland Wastewater Treatment Facility Selects MemCor™ MBR System for Expansion
DD - Australia's Largest Inland Wastewater Treatment Facility Selects MemCor™ MBR System for Expansion
EQUITY | Aug 11, 2026, 01:01 PM UTC
H
DuPont Faces Lawsuit
DuPont sued over chemical liabilities
REGULATION | Aug 06, 2026, 06:15 PM UTC
H
DuPont Says It Is Exploring M&A Opportunities in Water and Healthcare
DuPont de Nemours Inc. (NYSE: DD ) shares traded lower Tuesday after the company reported second-quarter 2026 results that beat analyst expectations and raised its full-year earnings outlook, as investors weighed the upd
EARNINGS | Aug 04, 2026, 06:15 PM UTC
H
DD - DuPont Reports Second Quarter 2026 Results
DD - DuPont Reports Second Quarter 2026 Results
EARNINGS | Aug 04, 2026, 12:57 PM UTC
H
DuPont de Nemours Raises FY2026 Adj EPS Guidance from $7.02-$7.16 to $7.17-$7.32 vs $7.13 Est; Narrows FY2026 Sales Guidance from $7.155B-$7
DuPont de Nemours (NYSE: DD ) raises FY2026 Adj EPS guidance from $7.02-$7.16 to $7.17-$7.32 vs $7.13 analyst estimate. Narrows FY2026 sales outlook from $7.155 billion-$7.215 billion to $7.160 billion-$7.190 billion vs
EARNINGS | Aug 04, 2026, 10:02 AM UTC
H
DuPont Q2 Adj EPS $1.88 Beats Estimate
DuPont reports Q2 earnings above estimates
EARNINGS | Aug 04, 2026, 10:01 AM UTC
H
Q APD DD among top names into earnings in chemicals preview @ RBC
Q APD DD among top names into earnings in chemicals preview @ RBC
EARNINGS | Jul 17, 2026, 11:55 AM UTC
L
DD, AMIX Split
Stock Splits for Wednesday June 24 DD 1-for-3 reverse AMIX 1-for-21 reverse
EQUITY | Jun 24, 2026, 09:06 AM UTC
L
DD, AMIX Split
DD and AMIX undergo reverse stock splits
EQUITY | Jun 23, 2026, 07:16 PM UTC
M
DD: Morgan Stanley Raises Target
Morgan Stanley maintains equal-weight rating on DuPont de Nemours and raises price target to $156
EQUITY | Jun 23, 2026, 05:05 PM UTC